Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Pavlos Msaouel, Giannicola Genovese, Jianjun Gao, Suvajit Sen & Nizar M. Tannir. (2021) TAM kinase inhibition and immune checkpoint blockade– a winning combination in cancer treatment?. Expert Opinion on Therapeutic Targets 25:2, pages 141-151.
Read now
Read now
Kathryn E. Crosier & Philip S. Crosier. (1997) New insights into the control of cell growth; The role of the Axl family. Pathology 29:2, pages 131-135.
Read now
Read now
Articles from other publishers (27)
Cristian Sandoval, Yolanda Calle, Karina Godoy & Jorge Farías. (2023) An Updated Overview of the Role of CYP450 during Xenobiotic Metabolization in Regulating the Acute Myeloid Leukemia Microenvironment. International Journal of Molecular Sciences 24:7, pages 6031.
Crossref
Crossref
Yunxiang Zhou, Yali Wang, Hailong Chen, Yanyan Xu, Yi Luo, Yongchuan Deng, Jianmin Zhang & Anwen Shao. (2021) Immuno-oncology: are TAM receptors in glioblastoma friends or foes?. Cell Communication and Signaling 19:1.
Crossref
Crossref
Jenna L. Carter, Katie Hege, Jay Yang, Hasini A. Kalpage, Yongwei Su, Holly Edwards, Maik Hüttemann, Jeffrey W. Taub & Yubin Ge. (2020) Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Ke Geng. 2020. TAM Receptors in Health and Disease. TAM Receptors in Health and Disease
35
55
.
Nellie K. McDaniel, Samantha R. Fischbach, Olivia J. Ondracek, Noah B. Welke, Mari Iida & Deric L. Wheeler. 2020. Improving the Therapeutic Ratio in Head and Neck Cancer. Improving the Therapeutic Ratio in Head and Neck Cancer
159
192
.
Pei-Ling Hsu, Jonathan Jou & Shaw-Jenq Tsai. (2019) TYRO3: A potential therapeutic target in cancer. Experimental Biology and Medicine 244:2, pages 83-99.
Crossref
Crossref
Sherri Smart, Eleana Vasileiadi, Xiaodong Wang, Deborah DeRyckere & Douglas Graham. (2018) The Emerging Role of TYRO3 as a Therapeutic Target in Cancer. Cancers 10:12, pages 474.
Crossref
Crossref
Martha Wium, Juliano Paccez & Luiz Zerbini. (2018) The Dual Role of TAM Receptors in Autoimmune Diseases and Cancer: An Overview. Cells 7:10, pages 166.
Crossref
Crossref
Guiling Wu, Zhiqiang Ma, Wei Hu, Dongjin Wang, Bing Gong, Chongxi Fan, Shuai Jiang, Tian Li, Jianyuan Gao & Yang Yang. (2017) Molecular insights of Gas6/TAM in cancer development and therapy. Cell Death & Disease 8:3, pages e2700-e2700.
Crossref
Crossref
Viralkumar Davra, Stanley Kimani, David Calianese & Raymond Birge. (2016) Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response. Cancers 8:12, pages 107.
Crossref
Crossref
Madeline Huey, Katherine Minson, H. Earp, Deborah DeRyckere & Douglas Graham. (2016) Targeting the TAM Receptors in Leukemia. Cancers 8:11, pages 101.
Crossref
Crossref
Gerhard Hamilton, Barbara Rath, Lukas Klameth & Maximilian Hochmair. (2015) Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer. Oncoscience 2, pages 629.
Crossref
Crossref
Douglas K. Graham, Deborah DeRyckere, Kurtis D. Davies & H. Shelton Earp. (2014) The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer. Nature Reviews Cancer 14:12, pages 769-785.
Crossref
Crossref
Abdellah Messoussi, Lucile Peyronnet, Clémence Feneyrolles, Gwénaël Chevé, Khalid Bougrin & Aziz Yasri. (2014) Structural Elucidation of the DFG-Asp in and DFG-Asp out States of TAM Kinases and Insight into the Selectivity of Their Inhibitors. Molecules 19:10, pages 16223-16239.
Crossref
Crossref
S P Whitman, J Kohlschmidt, K Maharry, S Volinia, K Mrózek, D Nicolet, S Schwind, H Becker, K H Metzeler, J H Mendler, A-K Eisfeld, A J Carroll, B L Powell, T H Carter, M R Baer, J E Kolitz, I-K Park, R M Stone, M A Caligiuri, G Marcucci & C D Bloomfield. (2013) GAS6 expression identifies high-risk adult AML patients: potential implications for therapy. Leukemia 28:6, pages 1252-1258.
Crossref
Crossref
Lutfi Suleiman, Claude Négrier & Habib Boukerche. (2013) Protein S: A multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. Critical Reviews in Oncology/Hematology 88:3, pages 637-654.
Crossref
Crossref
Stephen J. Demarest, Jennifer Gardner, Michelle C. Vendel, Eric Ailor, Suzanne Szak, Flora Huang, Adam Doern, Xiangyang Tan, Weixing Yang, Dorre A. Grueneberg, Edward J. Richards, Wilson O. Endege, Ed Harlow & Louise A. Koopman. (2013) Evaluation of Tyro3 Expression, Gas6-Mediated Akt Phosphorylation, and the Impact of Anti-Tyro3 Antibodies in Melanoma Cell Lines. Biochemistry 52:18, pages 3102-3118.
Crossref
Crossref
Yusuke Shiozawa, Elisabeth A. Pedersen, Lalit R. Patel, Anne M. Ziegler, Aaron M. Havens, Younghun Jung, Jingcheng Wang, Stephanie Zalucha, Robert D. Loberg, Kenneth J. Pienta & Russell S. Taichman. (2010) GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche. Neoplasia 12:2, pages 116-IN4.
Crossref
Crossref
O Mc Cormack, W Y Chung, P Fitzpatrick, F Cooke, B Flynn, M Harrison, E Fox, E Gallagher, A Mc Goldrick, P A Dervan, A Mc Cann & M J Kerin. (2008) Growth arrest-specific gene 6 expression in human breast cancer. British Journal of Cancer 98:6, pages 1141-1146.
Crossref
Crossref
Rachel M.A. Linger, Amy K. Keating, H. Shelton Earp & Douglas K. Graham. 2008.
35
83
.
Sassan Hafizi & Björn Dahlbäck. (2006) Gas6 and protein S. FEBS Journal 273:23, pages 5231-5244.
Crossref
Crossref
Paul W. FISHERMichael BRIGHAM-BURKESheng-Jiun WUJinquan LUOJill CARTONKim STAQUETWei GAOSheila JACKSONDeidra BETHEACailin CHENBing HUJill GILES-KOMARJing YANG. (2005) A novel site contributing to growth-arrest-specific gene 6 binding to its receptors as revealed by a human monoclonal antibody. Biochemical Journal 387:3, pages 727-735.
Crossref
Crossref
Lian-Xin Liu. (2002) Profiling of differentially expressed genes in human Gastric carcinoma by cDNA expression array. World Journal of Gastroenterology 8:4, pages 580.
Crossref
Crossref
Matthew Sleeman, Jonathan Fraser, Megan McDonald, Shining Yuan, Damian White, Prudence Grandison, Krishnanand Kumble, James D. Watson & J.Greg Murison. (2001) Identification of a new fibroblast growth factor receptor, FGFR5. Gene 271:2, pages 171-182.
Crossref
Crossref
Emeline Nandrot, Eric M Dufour, Alexandra C Provost, Marie O Péquignot, Sébastien Bonnel, Karı̈n Gogat, Dominique Marchant, Christelle Rouillac, Bertille Sépulchre de Condé, Marie-Thérèse Bihoreau, Cindi Shaver, Jean-Louis Dufier, Cécile Marsac, Mark Lathrop, Maurice Menasche & Marc M Abitbol. (2000) Homozygous Deletion in the Coding Sequence of the c-mer Gene in RCS Rats Unravels General Mechanisms of Physiological Cell Adhesion and Apoptosis. Neurobiology of Disease 7:6, pages 586-599.
Crossref
Crossref
Christine Darby, Diane M Giannola, Matthew S Couzens & Stephen G Emerson. (2000) ETK2 receptor tyrosine kinase promotes survival of factor-dependent FDC-P1 progenitor cells. Experimental Hematology 28:6, pages 716-725.
Crossref
Crossref
Yuka S. Nakamura, Yoshiyuki Hakeda, Nobuyuki Takakura, Takashi Kameda, Isao Hamaguchi, Takeshi Miyamoto, Shinji Kakudo, Toru Nakano, Masayoshi Kumegawa & Toshio Suda. (2009) Tyro 3 Receptor Tyrosine Kinase and its Ligand, Gas6, Stimulate the Function of Osteoclasts. STEM CELLS 16:3, pages 229-238.
Crossref
Crossref